Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-02-07 @ 9:44 AM
Study NCT ID:
NCT06674694
Status:
RECRUITING
Last Update Posted:
2025-11-17
First Post:
2024-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.
Sponsor:
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KL414-3-Ⅰ-01-CTP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None